Deutsche Bank’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-45,651
Closed -$275K 4881
2019
Q4
$275K Sell
45,651
-133,623
-75% -$805K ﹤0.01% 3008
2019
Q3
$644K Sell
179,274
-55,175
-24% -$198K ﹤0.01% 2544
2019
Q2
$626K Sell
234,449
-264,971
-53% -$707K ﹤0.01% 3105
2019
Q1
$1.48M Buy
499,420
+232,489
+87% +$688K ﹤0.01% 2702
2018
Q4
$423K Sell
266,931
-554,932
-68% -$879K ﹤0.01% 3397
2018
Q3
$3.02M Sell
821,863
-1,199,474
-59% -$4.41M ﹤0.01% 2570
2018
Q2
$5.72M Buy
2,021,337
+136,102
+7% +$385K ﹤0.01% 2196
2018
Q1
$6.99M Sell
1,885,235
-680,783
-27% -$2.52M ﹤0.01% 1928
2017
Q4
$7.39M Buy
2,566,018
+900,859
+54% +$2.59M ﹤0.01% 1708
2017
Q3
$7.47M Buy
1,665,159
+359,259
+28% +$1.61M 0.01% 1641
2017
Q2
$5.99M Sell
1,305,900
-145,793
-10% -$669K ﹤0.01% 1771
2017
Q1
$6.11M Sell
1,451,693
-339,629
-19% -$1.43M ﹤0.01% 1557
2016
Q4
$7.4M Buy
1,791,322
+26,047
+1% +$108K 0.01% 1442
2016
Q3
$14.3M Buy
1,765,275
+277,652
+19% +$2.25M 0.01% 1077
2016
Q2
$11.6M Buy
1,487,623
+120,769
+9% +$942K 0.01% 1212
2016
Q1
$10.6M Sell
1,366,854
-49,973
-4% -$386K 0.01% 1226
2015
Q4
$15.3M Buy
1,416,827
+709,723
+100% +$7.66M 0.01% 1072
2015
Q3
$4.88M Buy
707,104
+93,476
+15% +$646K ﹤0.01% 1820
2015
Q2
$5.43M Sell
613,628
-289,346
-32% -$2.56M ﹤0.01% 1735
2015
Q1
$8.9M Buy
902,974
+475,353
+111% +$4.69M 0.01% 1418
2014
Q4
$5.24M Buy
427,621
+79,954
+23% +$979K ﹤0.01% 1908
2014
Q3
$3.47M Buy
347,667
+118,117
+51% +$1.18M ﹤0.01% 2076
2014
Q2
$1.74M Sell
229,550
-289,602
-56% -$2.19M ﹤0.01% 2503
2014
Q1
$1.71M Buy
519,152
+202,409
+64% +$666K ﹤0.01% 2504
2013
Q4
$1.05M Buy
316,743
+76,087
+32% +$252K ﹤0.01% 2628
2013
Q3
$725K Buy
240,656
+52,655
+28% +$159K ﹤0.01% 3220
2013
Q2
$1.54M Buy
+188,001
New +$1.54M ﹤0.01% 2389